People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NextCure, Inc. | — | Biotechnology | Series C | $129.9M | $113.9M | 2025 |
| Vaccinex, Inc. | — | Pharmaceuticals | Series A | $45.9M | $936K | 2017 |
Steven P. Cobourn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven P. Cobourn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Judith Li | 1 | 8 |
| David Kabakoff | 1 | 7 |
| Michael Yi | 1 | 4 |
| Elaine V. Jones | 1 | 3 |
| ASHER RUBIN | 1 | 3 |
| Alan L. Crane | 1 | 3 |
| David P. Kabakoff | 1 | 2 |
| MICHAEL RICHMAN | 1 | 2 |
| CAROLYN GREEN | 1 | 2 |
| John G. Houston | 1 | 2 |
| Ellen G. Feigal | 1 | 1 |
| Sourav G. Kundu | 1 | 1 |
| JUDITH Q. LI | 1 | 1 |
| Stephen G. Webster | 1 | 1 |
| Anne G. Borgman | 1 | 1 |
| Udayan G. Guha | 1 | 1 |
| Stella Xu | 1 | 1 |
| Kevin G. Shaw | 1 | 1 |
| Timothy G. Mayer | 1 | 1 |
| CHAU Q. KHUONG | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.